This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Winners & Losers: Invitrogen

A few analyst actions in the health stocks: Citigroup analyst Lucy Lu downgrade BioMarin (BMRN - Get Report) to hold from buy and lowered her price target to $37 from $42, after surveying 26 treatment centers on Kuvan, a drug for the genetic disorder phenylketonuria (PKU), and subsequently lowering sales and profit expectations.

The stock traded down 3.3% to $34.47.

Also, HSBC Securities downgraded Novartis (NVS - Get Report) to underweight from neutral and lowered its price target to $49 from $52. The stock was off by just 8 cents, or 0.2%, at $50.35.

In other health stocks, Lehman Brothers downgraded Lifepoint Hospitals (LPNT - Get Report) to equal-weight from overweight but the stock was seemingly unaffected, adding 83 cents, or 2.9%, to $29.77.

And Tenet Healthcare (THC) added 39 cents, or 7.4%, to $5.69 after Lehman Brothers analyst Adam Feinstein upgraded the stock to overweight from equalweight, citing new contracts and potential growth despite industry hardships.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABI $22.98 1.01%
BMRN $67.26 0.36%
LPNT $65.92 -5.06%
NVS $72.20 -1.08%
AAPL $93.70 -0.60%


Chart of I:DJI
DOW 15,660.18 -254.56 -1.60%
S&P 500 1,829.08 -22.78 -1.23%
NASDAQ 4,266.8370 -16.7550 -0.39%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs